These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24295368)
1. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility. Song GG; Lee YH Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368 [TBL] [Abstract][Full Text] [Related]
2. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis. Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738 [TBL] [Abstract][Full Text] [Related]
3. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759 [TBL] [Abstract][Full Text] [Related]
4. The chemokine receptor 5 delta32 polymorphism and type 1 diabetes, Behcet's disease, and asthma: a meta-analysis. Song GG; Kim JH; Lee YH Immunol Invest; 2014; 43(2):123-36. PubMed ID: 24171669 [TBL] [Abstract][Full Text] [Related]
5. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Lee YH; Bae SC; Song GG Mod Rheumatol; 2013 Mar; 23(2):304-10. PubMed ID: 22638733 [TBL] [Abstract][Full Text] [Related]
6. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis. Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861 [TBL] [Abstract][Full Text] [Related]
7. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis. Zhou TB; Jiang ZP; Zhou JF; Su N Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769 [TBL] [Abstract][Full Text] [Related]
8. Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis. Lee YH; Song GG J Recept Signal Transduct Res; 2015; 35(6):509-15. PubMed ID: 25203595 [TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations. Lee YH; Kim JH; Song GG Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359 [TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis. Møller M; Søndergaard HB; Koch-Henriksen N; Sorensen PS; Sellebjerg F; Oturai AB Acta Neurol Scand; 2014 Jan; 129(1):27-31. PubMed ID: 23668375 [TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease. Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752 [TBL] [Abstract][Full Text] [Related]
12. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378 [TBL] [Abstract][Full Text] [Related]
13. Influence of CCR5-Delta32 genotype in Spanish population with multiple sclerosis. Otaegui D; Ruíz-Martínez J; Olaskoaga J; Emparanza JI; López de Munain A Neurogenetics; 2007 Aug; 8(3):201-5. PubMed ID: 17351762 [TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor V Δ32 deletion in multiple sclerosis patients in Csongrád County in Hungary and the North-Bácska region in Serbia. Török N; Molnár K; Füvesi J; Karácsony M; Zsiros V; Fejes-Szabó A; Fiatal S; Ádány R; Somogyvári F; Stojiljković O; Vécsei L; Bencsik K Hum Immunol; 2015 Jan; 76(1):59-64. PubMed ID: 25500253 [TBL] [Abstract][Full Text] [Related]
15. Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis. Silva-Carvalho WH; de Moura RR; Coelho AV; Crovella S; Guimarães RL Infect Genet Evol; 2016 Sep; 43():101-7. PubMed ID: 27208805 [TBL] [Abstract][Full Text] [Related]
16. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility. Srivastava A; Pandey SN; Choudhuri G; Mittal B Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329 [TBL] [Abstract][Full Text] [Related]
17. Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis. Liu S; Kong C; Wu J; Ying H; Zhu H PLoS One; 2012; 7(4):e35020. PubMed ID: 22496885 [TBL] [Abstract][Full Text] [Related]
18. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms. Sandford B; Bown M; London N; Sayers R Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483 [TBL] [Abstract][Full Text] [Related]